
During the Samanvay 2025 summit in Bengaluru, the Defence Research and Development Organisation announced a key step to strengthen Indian defence manufacturing. By handing over 12 licensing agreements for 8 innovative products, the organisation aims to enable broader production and technology adoption among domestic firms.
DRDO’s handover of 12 licensing agreements covers 8 specialised products, ranging from electronic warfare systems to industrial laser spectroscopy. The move is part of a broader initiative to convert research inventions into commercialised capabilities, aligning with the government’s self-reliance objective.
The handover session, held on a day of the 2-day industry synergy summit, attracted more than 150 industry representatives, including MSMEs and start-ups. The event offered insights into DRDO’s industry-friendly policies and the newly launched Industry Interaction Group, which will facilitate ongoing dialogue between research labs and commercial entities.
Read More: Indian Army Signs Deal for First Indigenous IDDM and SDRS Systems from DRDO and BEL!
By transferring licences for 8 high-tech products, DRDO expects to decentralise production and accelerate commercial deployment. This collaboration is intended to reduce import reliance, foster technology transfer, and stimulate job creation across the defence sector.
The summit’s agenda will include sessions on refining DRDO’s policies, addressing manufacturing challenges, and creating avenues for start-ups to join production chains. These discussions are expected to further ease access to cutting-edge defence technology.
DRDO’s 12 licensing agreements for 8 technologies mark a significant push toward self-sufficiency in India’s defence industry. The move promises to broaden industrial participation, enhance domestic production, and support the nation’s Make in India aspirations.
Disclaimer: This blog has been written exclusively for educational purposes. The securities or companies mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all the related documents carefully before investing.
Published on: Oct 30, 2025, 2:08 PM IST

Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates